OHLCX Market Research
Delayed

ZTS

Zoetis Inc. is a global leader in animal health, providing products and services for livestock and companion animals.

−2.63 (−3.26%) Nov 20, 2026 19:42 ET Delayed
Open
80.85
High
83.08
Low
78.00
Prev close
80.79
Volume
6M
Avg vol 10
5M

Today · Market closed · opens Mon 9:30 AM

Price

ZTS chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 78.16

Strong sellNeutralStrong buy
Sell
score −0.22 · 18 signalling
2Buy
10Neutral
6Sell

Leaning sell. 6 of 18 signals point down against 2 up, carried by trend and volume. Momentum is mostly neutral. Volatility is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is strong (ADX 31).

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 1.18 · Signal 1.77 · Hist −0.60
Sell
ADX 14
Strong trend, +DI ahead
ADX 31.24 · +DI 25.70 · −DI 20.48
Buy
Parabolic SAR 0.02, 0.2
Above price, 9.18 over the close
87.34
Sell
Ichimoku 9, 26, 52
Price above cloud, conversion below base
Conv 82.37 · Base 83.16 · A 74.02 · B 74.19
Neutral

Momentum

RSI 14
Mid-range, no extreme
44.52
Neutral
Stoch 14, 3
Oversold, %K still below %D
%K 0.00 · %D 28.46
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K still below %D
%K 13.30 · %D 22.42
Neutral
Williams %R 14
Oversold zone, falling
−100.00
Neutral
CCI 14
Below −100, still falling
−137.43
Neutral
MFI 14
Above midpoint, not overbought
54.29
Neutral
ROC 12
Price down 12.38% over 12 bars
−12.38%
Sell
AO 5, 35
Above zero, falling
3.73
Neutral
TRIX 18
Above zero
0.335
Buy
KST 10/15/20/30, 3
Below its signal line
KST 90.42 · Signal 95.22
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.16
Up 87.44 · Mid 81.95 · Low 76.45
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 86.13 · Mid 81.46 · Low 76.79
Neutral

Volume

VWAP 345-bar
Close 24.3% below VWAP
103.29
Sell
Force Index 1
Negative, sellers in control
−16.0M
Sell
ATR
2.92
3.73% of close
A/D Line
−101.8M
cumulative
OBV
−131.4M
cumulative
Volume Profile
75.32 – 81.87
POC · bull 264.7M · bear 365.7M · 42 / 58
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-3.52%

Change in value over the past month.

3 month return

2.51%

Change in value over the last three months.

Max drawdown

47.29%

Largest fall from a peak to the low that followed.

Standard deviation

39.75%

How far daily returns stray from their average, annualised.

Sharpe ratio

-1.10

Return above the risk-free rate per unit of volatility.

Calmar ratio

-0.93

Annualised return against the maximum drawdown.

About

ZTS summary

Loading summary…

Questions

ZTS, answered

What is Zoetis’s growth strategy?

Zoetis’s growth strategy focuses on expanding its product portfolio, investing in research and development, and increasing global market presence.

Where can customers find more information about Zoetis’s products?

Customers can visit Zoetis’s official website for detailed information on animal health products and services.

In which markets does Zoetis operate?

Zoetis operates globally, serving customers in over 100 countries.

How does Zoetis contribute to animal health?

Zoetis contributes to animal health through innovative solutions that improve the health and well-being of animals.

How can investors track ZTS’s financial performance?

Investors can track financial performance through quarterly earnings reports, annual filings, and Zoetis’s investor relations website.

What are Zoetis’s future plans for innovation?

Zoetis plans to continue investing in innovation to develop new products and technologies that enhance animal health and welfare.

Who are Zoetis’s main competitors?

Main competitors include Merck Animal Health, Elanco Animal Health, and Bayer Animal Health.

How does Zoetis engage with its customers?

Zoetis engages with its customers through educational programs, webinars, and support services for veterinarians and livestock producers.

When was Zoetis founded?

Zoetis was founded in 1952 as a division of Pfizer and became an independent company in 2013.

What are Zoetis’s key financial metrics?

Key financial metrics include revenue growth, profit margins, and earnings per share (EPS).

News

ZTS in the news

Advance Your ZTS Trading Now

Revolutionize your investment in ZTS with OHLCX execution platform’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Start optimizing your trades today with OHLCX execution platform now and achieve better trading outcomes!

Experience Excellence Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.